Biomedical imaging systems and novel engine components received top billing in the 2019 Institute of Physics Business Awards
Read article: Engines and imagers dominate awards for physics-based innovations
Alpha therapy targeting a protein in the tumour stroma could provide a new treatment for pancreatic cancer
Read article: Targeted treatment guides radiation directly to pancreatic tumours
Microbeam radiation therapy reduces growth of radioresistant mouse melanoma by disrupting tumour vascular and stimulating the influx of immune cells
Read article: Tiny radiation beams tackle radioresistant melanoma
New technique for performing multiple lengthy breath-holds will enable patients to hold their breath during prolonged bouts of radiotherapy
Read article: Breath-hold technique reduces patient motion during radiotherapy
The MR-linac allows treatment plan adaption to the patient's daily anatomy – but how can we tell whether the new plan is suitable for delivery?
Read article: Software offers ‘sanity check’ for adapted plans in MR-guided radiotherapy
The first prospective study of MR-guided hypofractionated radiotherapy in prostate cancer patients demonstrates particularly low toxicity
Read article: MRI guidance minimizes toxicity in prostate cancer radiotherapy
At the ASTRO Annual Meeting, researchers unveil the latest research in areas such as cardiac radioablation, immunotherapy and machine learning
Read article: ASTRO: highlighting radiation oncology breakthroughs
Standard Imaging’s Adaptivo software tracks and reports the dosimetric impact of changes in patient anatomy and positioning during the course of radiation treatment
Read article: Dosimetry software captures daily, cumulative patient trends
Motion synchronization, adaptive planning and treatment versatility will unlock the full potential of hypofractionated radiotherapy for value-based cancer care
Read article: Hypofractionation: a new value proposition in radiation oncology
The PERTAIN trial is examining the impact of FDG PET/CT-guided chemoradiotherapy for lung cancer patients in low- and middle-income countries
Read article: PET/CT-guided chemoradiotherapy improves lung cancer outcomes
